Name of leader and affiliation
Justin Green, DDW Programme
GlaxoSmithKline (GSK) is a major international pharmaceutical company dedicated to bringing effective medicines to patients. GSK has a heritage and expertise in researching and developing new medicines and vaccines and is committed to searching for new treatments for many of the diseases that affect millions of people in some of the world´s least well off nations. Technical and scientific resources GSK is devoting to this important area include a specialized research centre in Spain (Diseases of Developing World Medicines Development Centre, DDW MDC) which carries out research into global health priorities like malaria and tuberculosis. DDW MDC has a strong experience in research of new anti-infective and is equipped with state-of-the-art BSL3 facilities to work in vitro and in vivo with pathogenic bacteria and parasites. We are currently working under private-public partnership with groups including Medicines for Malaria Venture (MMV) and the Global Alliance for TB drug development (GATB).
Sorry, no posts found for this author.